TILT Biotherapeutics

TILT Biotherapeutics

Bibliographic Details
Main Author:	Akseli Hemminki
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-05-01
Series:	Human Vaccines & Immunotherapeutics
Online Access:	http://dx.doi.org/10.1080/21645515.2017.1298962

Similar Items

Integrated BioTherapeutics
by: M. Javad Aman
Published: (2018-06-01)

Emerging protein biotherapeutics /
by: Grewal, Iqbal S.
Published: (2009)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
by: Kyle P. Martin, et al.
Published: (2023-12-01)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
by: Roy Jefferis
Published: (2016-01-01)

Anaphylaxis and the inclusion of polysorbates in biotherapeutics
by: Edward Maggio
Published: (2017-12-01)

Editorial: Characterization of biotherapeutic products
by: Anurag S. Rathore, et al.
Published: (2022-09-01)

The Development Pathway for Biosimilar Biotherapeutics
by: Marco Zarbin
Published: (2020-08-01)

Biotherapeutics and its applications in Microbiology
by: Navjot Kaur, et al.
Published: (2021-03-01)

In silico tools for the development of biotherapeutics
by: Lauer, Timothy Michael
Published: (2016)

Oncolytic Immunotherapy: Where Are We Clinically?
by: Akseli Hemminki
Published: (2014-01-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
by: Akseli Hemminki
Published: (2012-08-01)

Development of targeted exosomes for delivery of biotherapeutics
by: Willms, E
Published: (2018)

Electrostatic Gelatin Nanoparticles for Biotherapeutic Delivery
by: Connor Tobo, et al.
Published: (2024-11-01)

Exposing the molecular heterogeneity of glycosylated biotherapeutics
by: Luis F. Schachner, et al.
Published: (2024-04-01)

Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics
by: Tom Zaplana, et al.
Published: (2024-01-01)

IgY Antibodies as Biotherapeutics in Biomedicine
by: Diana León-Núñez, et al.
Published: (2022-09-01)

Live Biotherapeutic Products and Probiotics for the Skin
by: Ava M. Vargason, et al.
Published: (2021-12-01)

Pediatric Dosing and Body Size in Biotherapeutics
by: Hartmut Derendorf, et al.
Published: (2010-12-01)

Regulatory Pathway for Licensing Biotherapeutics in Mexico
by: Carlos A. López-Morales, et al.
Published: (2018-09-01)

Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins
by: Nico Betterle, et al.
Published: (2020-03-01)

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
by: Anshu Kuriakose, et al.
Published: (2016-01-01)

Antibiotic-Free Selection in Biotherapeutics: Now and Forever
by: Charlotte Mignon, et al.
Published: (2015-04-01)

Engineering Components of the Lactobacillus S-Layer for Biotherapeutic Applications
by: Courtney Klotz, et al.
Published: (2018-10-01)

Editorial: Synthetic Live Biotherapeutic Products for Diseases
by: Ye Chen, et al.
Published: (2022-03-01)

Rational design in functional hydrogels towards biotherapeutics
by: Yang Yang, et al.
Published: (2022-11-01)

Potentials and limitations of microorganisms as renal failure biotherapeutics
by: Poonam Jain, et al.
Published: (2009-05-01)

Engineering targeted proteins for intracellular delivery of biotherapeutics
by: Pirie, Christopher M
Published: (2013)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
by: Akseli Hemminki, et al.
Published: (2021-10-01)

Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
by: Riikka Havunen, et al.
Published: (2021-01-01)

Oncolytic adenovirus for treatment of malignant ascites
by: Akseli Hemminki, et al.
Published: (2022-09-01)

Serotype Chimeric Human Adenoviruses for Cancer GeneTherapy
by: Akseli Hemminki, et al.
Published: (2010-09-01)

An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis
by: Cubillos-Ruiz, Andrés, et al.
Published: (2023)

Development of biotherapeutic agent for the treatment and prevention of gastroenteritis in children
by: Abdul Manap, Yazid, et al.

Clinical application of live biotherapeutic products in infectious diseases
by: Bhagyashri D. Navalkele, et al.
Published: (2024-07-01)

Microbiota-directed biotherapeutics: considerations for quality and functional assessment
by: Emily Ef Fekete, et al.
Published: (2023-12-01)

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
by: Xiaotian Zhong, et al.
Published: (2021-03-01)

Metabolic Profiling of CHO Cells during the Production of Biotherapeutics
by: Mathilde Coulet, et al.
Published: (2022-06-01)

Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.
by: Charles N Rudick, et al.
Published: (2014-01-01)

Engineered Bacteria-Based Living Materials for Biotherapeutic Applications
by: Rabia Omer, et al.
Published: (2022-04-01)

Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential
by: Prateeksha, et al.
Published: (2019-02-01)